Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

Earnings: why AstraZeneca shares are climbing

| Alan Oscroft

AstraZeneca shares have stormed ahead as the company's long-term rebuild is delivering revenue growth. Results for 2022 are here.

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

These were the FTSE 100’s biggest flops in January!

| Cliff D'Arcy

The FTSE 100 index had a good January, rising by 4.3%. While the shares of 86 Footsie firms rose last…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Page

Top UK Large-Cap Stocks of 2026

| Zaven Boyrazian, CFA

Discover the expansive world of UK large-cap stocks and learn how these can provide stability and income to an investment…

Read more »

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

Tempted by the AstraZeneca share price? Here’s why it could explode in 2023

| Charlie Carman

The AstraZeneca share price has more than doubled over five years. Our writer outlines why the FTSE 100 healthcare stock…

Read more »

Inflation in newspapers
Investing Articles

2 inflation-resistant stocks I’d like to buy right now

| Ben McPoland

These two firms are on my 'stocks to buy' list for when I have more cash to invest. Both seem…

Read more »

Investing Articles

3 ‘no-brainer’ FTSE 100 shares I’d buy for 2023

| Harshil Patel

FTSE 100 top picks! Our writer considers diversification, resilience and business quality to find the best shares for his ISA…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

Revealed! The most sold FTSE 100 stocks by Hargreaves Lansdown investors

| Royston Wild

Demand for these FTSE 100 stocks sank among Hargreaves Lansdown clients this year. But could they rebound in 2023?

Read more »

Investing Articles

Are AstraZeneca shares a growth buy for 2023?

| Roland Head

AstraZeneca's surging share price has made it the most valuable business in the FTSE 100. Roland Head analyses what's next…

Read more »

Investing Articles

Top 2 FTSE 100 shares to buy for 2023

| Harshil Patel

2023 FTSE 100 top picks are here! Our writer takes an early look at the best shares to buy for…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

If I’d invested £500 in AstraZeneca shares 2 years ago, here’s how much I’d have now!

| Dr. James Fox

Dr James Fox explores whether AstraZeneca shares are right for his portfolio after two years of strong share-price growth.

Read more »

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

Best British shares to buy in November

| The Motley Fool Staff

We asked our writers to share their ‘best of British’ stocks to buy this month, including insurers and housebuilders.

Read more »

Young female analyst working at her desk in the office
Investing Articles

What on earth is going on with the AstraZeneca share price?

| Kevin Godbold

Is recent weakness in the AstraZeneca share price a buying opportunity for me after 10 years of impressive performance?

Read more »